Recent NIAID Technology Development Licensing and Collaboration Opportunities

Biodefense

Cancer

Diagnostic Research Agents

Fungal Diseases

HIV/AIDS

The Use of Chimeric Antigen Receptor to Control HIV Infection

A Novel Fusion Protein for Inhibiting HIV Budding

Recombinant Sulfated HIV Envelope Protein and Methods for Making Protein

Bispecific Antibodies To Target Latent HIV-1 Infection

The Use of alpha-4 beta-7 Integrin Inhibitors To Inhibit HIV Transmission and Infection

Multi-Specific Chimeric Antigen Receptors Against HIV

A Broadly Neutralizing Human Anti-HIV Monoclonal Antibody (10E8) Capable of Neutralizing Most HIV-1 Strains

HIV-Neutralizing Polypeptides: A Novel Use for Platelet Factor 4 or Its Derivatives

Multi-Specific Chimeric Antigen Receptors Against HIV

The Use of Chimeric Antigen Receptor To Control HIV Infection

A Method to Expand a Population of Regulatory T Cells Optimal for the Treatment of Autoimmune Diseases

HIV Monoclonal Antibodies

Intestinal Bowel Disease

Research Material

Sample Preparation

Therapeutics, Diagnostics, and Preventatives

Vaccines and Vaccine Delivery

Content last reviewed on October 27, 2016